1/160
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
nicotine
nAChR Agonist
tubocurarine
non-selective
hexomethonium
selective for Nn (nic nerve) over Nm(muscular)
nAChR Antagonist
muscarine
acetylcholine
both mus and nic agonist
carbachol
slightly better nic agonist
methacholine
slightly better mus agonist
mAChR Agonist
atropine
hyoscine
ipatropium
bronchodilation
mAChR Antagonist
phenylephrine
α₁ adrenoceptor Agonist
prazosin
α₁ adrenoceptor Antagonist
clonidine
alpha 2 adrenoceptor Agonist
yohimbine
alpha 2 adrenoceptor Antagonist
dobutamine
beta 1 adrenoceptor Agonist
atenolol
beta 1 adrenoceptor Antagonist
salbutamol
beta 2 adrenoceptor Agonist
butoxamine
beta 2 adrenoceptor Antagonist
Pharmacodynamics
Drug on Body
Pharmacokinetics
Body on Drug
1. Absorption
2. Distribution
3. Metabolism
4. Excretion
4 Parts of Pharmacokinetics
Formal Chemical Name
Code Name
Generic (non-proprietary) Name
Trade (proprietary) Name
Drug Naming Types
Isopropyl
Formal Chemical Name Ex.
D-135
Code Name Ex.
verapamil
no caps
Generic (non-proprietary) Name
Univer
CAPS
Trade (proprietary) Name
Diffusion
Active Transport
Pinocytosis
Like Endocytosis
3 Main Ways of Drug Membrane Transport
Lipid Diffusion
Common Route of Membrane Transport
Concentration gradient
SA of membrane
Permeability coefficient (hydrophobic is better)
Diffusion depends on...
Lipid Diffusion
Good for small hydrophobic drugs
Aqueous Diffusion
Passes between endothelial cells
Two types of diffusion
Binds with a biomolecule to form a complex
Ligand
A ligand that exists naturally within the body
Endogenous ligand
the drug is 50% ionized
Drug pH = the pH when
membranes block ions from crossing
Ion Trappin
Uncharged forms
What crosses membranes better, charged or uncharged forms?
Most drugs are weak acids or weak bases
Common pH of drugs
blood vessel endothelial cells are woven very tightly on top of each other. hydrophilic molecules can't leave!
Blood-brain barrier difference
Like endocytosis
Receptor mediated
For large proteins
Pinocytosis
Enteral
oral
Parenteral
all other routes
Enteral vs Parenteral
Convenient
Efficient
Large SA of GIT
Mixing w gut muscles
Variety of pH's in GIT
Microvili in intestine increases SA
Pros of Enteral Route
Drug can't be acid dissolved
Broken down by GIT enzymes
Cons of Enteral Route
Proportion of dosage that enters systemic circulation (100 for iv)
Bioavailability
First Pass Metabolism
When drugs get broken down the first time thru the liver. Not very effective
FPM
Inhalation
Topical
Transdermal
Buccal
Injection (iv, intramuscular, subcutaneous)
Parenteral Routes
High blood flo thru lungs
Inhalation
Local application ot body surface
Works at site of application
Topical
Slow absorption
Unlike topical, treats all over
Transdermal
Under tongue
Goes right into systemic circulation
Good for drugs with high FPM
Buccal
Bioavailability is LOW (not much reaches target)
I. V.
Most direct
Hazardous
Intramuscular
Absorption determined by bloodflow
Subcutaneous
Slow absorption
Sustained release forms
Injection
pH= pKa + log (protonated/unprotonated)
Henderson-Hasselbach Eq.
Vd= Amount drug/ Drug Concentration in Plasma
3.5 L Blood
10 L Interstitial fluid
28 L Intracellular fluid
Volume distribution
1. Blood flow
2. Ginding to proteins to help keep drug in the vascular system
Albumin (acidic drugs)
Alpha 1 (basic drugs)
Two factors that affect distribution
Hydrophilic
To extreme are drugs made more hydrophobic or philic
Drug > Derivative > Conjugate
Phase 1
Made polar by adding func groups OH NH2 etc
Phase 2
Condensation w/ hydrophilic group
Metabolism Mechanism
Oxidize wide range of chemicals
Low substrate specificity
Oxidize phase 1 reaction
Smooth ER
P450 Enzymes
Interferes with P450 enzymes
1. Competitive
Namesake
2. Direct
Suicide inactivates bind irreversibly
3. Depletion of cofactors
Metabolic Enzyme Inhibition
Age and Gender
Enzyme Inhibition
Metabolism Influenced by
Glomerular Filtration
Drugs filtered into urine
Tubular Secretion
Active transport w/ acid and base carriers
Two Routes of Kidney Excretion
Cp= C₀e^(-Kel * t)
Kel= 0.693/(half life time)
Half Life Equation
F= 1-(0.5)^(time/time taken for half life)
Fraction of new level of drug approached
D + R ⇌ DR → Response
Rate forward= k1 [D][R]
Rate reverse= k2 [DR]
[DR] = [D][R]/Ka
Receptor-Drug Interaction
Mimics endogenous ligand
Promotes
Agonist
The concentration required to get an EC50 response
Potency
The maximal effect of a drug
Efficacy
Two chemicals produce opposite effects, but acting through separate receptor systems
Physiological Antagonism
Causes drug to drop out of soln via precipitation
Chemical Antagonism
Ex. Accelerating metabolism
Pharmacokinetic Antagonism
Classical antagonism thru receptor mediation
Pharmacodynamic Antagonism
Resting state ⇌ Activated state →Response
Antagonist binds both states equally
Inverse agonist prefers resting state
Agonist prefers activated state to various degrees (partial vs. full agonist)
Two State Receptor Model
Effective dose in 50 percent of the population
ED50
Toxic does in 50 percent of the population
TD50
Between effectiveness and toxicity
Therapeutic window
1. Ion Channels
2. G-Protein Coupled Receptors
3. Kinase-linked Receptors
4. Intracellular Receptors
Types of Cell Receptors (4)
Ligand gated
Conduct small charged molecules
Alter membrane potential
Ion Channels
Capable of variety of signals due to second messengers
Steps
Ligand binds to thrombin receptor
Thrombin receptor alters g protein and GDP becomes GTP
This splits the alpha from the beta and the gamma sections of the protein
The alpha section then goes to another protein on the membrane, which can vary
This second protein then sends out a second messenger which is the cell signal
G Protein-Coupled Receptors
cAMP
cGMP
Diacylglyceral + IP3
Ca2+
Second Messengers
ARE enzymes
Extracellular ligand binding site
alpha helix crossing the membrane
Intracellular kinase
Kinase Linked Receptors
Activates receptor in the cell itself
alters gene transcription
Mediate cell response to
Steroids
Thyroid hormones
Lipids- fatty acids (PPAR) and cholesterol (LXR)
Intracellular Receptors
Bind fatty acids and fatty acid metabolites
Regulate genes that regulate lipid/carb metabolism and transport
PPARs
Sympathetic system
NA
alpha and beta adrenoceptors
fight or flight
Adrenergic system
Parasympathetic system
ACh
M and N cholinoceptors
digest and rest
Cholinergic system
reduce heart output, causes sweating, salivation and bronchiole secretion
Muscarinic agonists
tachycardia, excitatory CNS effects such as agitation and disorientation
Muscarinic antagonist effect on the heart
noradrenalne> adrenaline > isoprenaline
alpha agonist potency
isoprenaline> adrenaline> noradrenaline
beta agonist potency
Involuntary
Sympathetic, parasympathetic and enteric
Autonomic NS
AChE
Acetylecholinesterase
Turns Acetylecholine back into choline
Enzyme for ACh
Choline acetyletransferase takes choline and turns it into ACh
ACh synthesis
Nm- muscle type
Nn- nerve type
Nicotinic Receptor sub-types
M1- neural
M2- cardiac
M3- glandular
Muscarinic Receptor sub-types
muscarinic excess
nausea, vomiting, vasodilation, sweating, diarrhea
Mushroom Poisoning
Increase the response of the body to ACh because they block the breakdown of the neurotransmitter
insectisides
short/medium/long block of ser203
Short
Quaternary alcohols
Medium
Carbamyl esters (neostigmine and physostigmine
Irreversible
Pentavalent phosphorus compounds
AChE inhibitors
Receptors
AChE
Cholinergic drug targets
Receptors
Reuptake transporters
Monoamine Oxidase (MaO)
Catchecol-o-methyl transferase (COMT)
Adrenergic drug targets
excitatory effects (except in gut)
alpha adrenoceptors role
excitatory effects (except in heart)
beta adrenoceptors role
5-HT (hydroxytryptamine)
Acts via 5-HT receptors 1-5
5-HT1 agonist sumatriptan helps w migrains
5-HT2 agonist include LSD and 2c-p
Seratonin
Stored in granules in mast cells and basophils
Histamine
mimic morphine
Analgesic NOT anesthetic
Receptors μ δ κ ORL1
G protein coupling opens K+ channels causing the pain-killing effect
CNS Depressants- Opioids
Role in causing pain
Blocked by NSAIDs
Eicosanoids
Cholinergic agonist
AChE inhibitor
Encourages parasympathetic system in this way
Parasympathomimetic drug
Physostigmine
Cholinergic agonist
Activates acetylecholine receptor
Carbachol
Competitive antagonist of muscarinic cholinoceptors M1-5
Atropine
Blocks nicotinic cholinoceptors
Tubocurarine
Excites muscarinic cholinoceptors
Causing contraction
ACh role on ileum
Causes relaxation thru inhibitory β-adrenoceptors
NA role on ileum